Back to search

Article

Circulating Tumor DNA (ctDNA) Methylation Quantification As Diagnostic Biomarker of Pheochromocytomas (PCCs) and Paragangliomas (PGLs)

2023-04-17

Abstract excerpt

<h4>Introduction: </h4> Circulating tumor DNA (ctDNA) is newly diagnosed tumor DNA that can easily represent a tumor’s genetic and epigenetic change. Pheochromocytomas (PCCs) and Paragangliomas (PGLs) are rare tumors of adrenal gland tissue that have the potential to be detected by ctDNA. We aimed to study the potential of the methylation status of RDBP, SDHB, and SDHC genes in ctDNA of PCCs/PGLs patients as a dia...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9136f121-a47a-5efb-aa75-d4a4b23da69a
DOI
10.20944/preprints202304.0404.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Circulating Tumor DNA (ctDNA) Methylation Quantification As Diagnostic Biomarker of Pheochromocytomas (PCCs) and Paragangliomas (PGLs)DOI 10.20944/preprints202304.0404.v1
Exosomal double-stranded DNA as a biomarker for the diagnosis and preoperative assessment of pheochromocytoma and paragangliomaSemantic proximity
Integrated ctDNA Methylation Profiling of P2RX1, CBFA2T3, and CERS4 as Pancreatic Ductal Adenocarcinoma Biomarkers: Identification and Mechanistic InsightsSemantic proximity
Detection of Circulating Tumor-specific DNA Methylation Markers in the Blood of Patients with Pituitary TumorsSemantic proximity
Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profilesSemantic proximity
Risk Stratification on Pheochromocytoma and Paraganglioma from Laboratory and Clinical MedicineSemantic proximity
Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profilesSemantic proximity
Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new eraSemantic proximity
Methylated circulating tumor DNA in blood: power in cancer prognosis and responseSemantic proximity
Risk Stratification on Pheochromocytoma and Paraganglioma from Laboratory and Clinical MedicineSemantic proximity
Circulating cell‐free <scp>DNA</scp> methylation‐based multi‐omics analysis allows early diagnosis of pancreatic ductal adenocarcinomaSemantic proximity
Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas.Semantic proximity
HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: Metastatic pheochromocytomas and paragangliomas: proceedings of the MEN2019 workshopSemantic proximity
Select a neighboring publication to make it the new centre.